{"id":347324,"date":"2026-11-14T22:00:03","date_gmt":"2026-11-14T16:30:03","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/gufic-biosciences-q2-results-fy27-pat-23-crore\/"},"modified":"2026-11-14T22:00:03","modified_gmt":"2026-11-14T16:30:03","slug":"gufic-biosciences-q2-results-fy27-pat-23-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/gufic-biosciences-q2-results-fy27-pat-23-crore\/","title":{"rendered":"Gufic Biosciences Q2 Results FY27: Net Profit Rises 39.54% YoY, Revenue Rs 288.27 Cr, PAT Rs 23.47 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Gufic Biosciences Q2 Results FY27 were declared on 14 November 2026 for the July to September 2026 quarter on a Consolidated basis. Revenue rose 21.61% YoY to Rs 288.27 Cr from Rs 237.05 Cr, and net profit (PAT) rose 39.54% to Rs 23.47 Cr from Rs 16.82 Cr. These quarterly results show positive YoY growth in all three lines, with Operating Profit up 28.11% to Rs 48.49 Cr.<\/p>\n<\/div>\n

Gufic Biosciences Ltd<\/a> (GUFICBIO) Q2 Results FY27 announced on 14 November 2026, covering the company’s financial performance for the July to September quarter. The results date marks the filing, and the consolidated results show revenue of Rs 288.27 Cr and PAT of Rs 23.47 Cr. Gufic Biosciences Q2 Results FY27 therefore pair a 21.61% revenue rise with a 39.54% rise in net profit.<\/p>\n

This Univest note on Gufic Biosciences Q2 Results covers the financial highlights, business drivers, outlook and risks. The results analysis starts from the Financial Highlights table below, which sets each figure beside the same quarter a year ago.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n